Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
an lei wu
(45 results)?
Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors.
Clin Transl Oncol. 2022 Oct;24(10):1975-1985. doi: 10.1007/s12094-022-02854-3. Epub 2022 Jun 6.
Clin Transl Oncol. 2022.
PMID: 35666454
Six first-line tyrosine kinase inhibitors reveal novel inhibition potential for the EGFR S768I mutation.
Wang Y, Liu Q, Chu C, Li L, Wang Z, Liu Q, Wu G, Wei X, An L, Ma J.
Wang Y, et al.
Toxicol Appl Pharmacol. 2023 Feb 15;461:116385. doi: 10.1016/j.taap.2023.116385. Epub 2023 Jan 20.
Toxicol Appl Pharmacol. 2023.
PMID: 36682591
Item in Clipboard
Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors.
Liu C, Wang Z, Liu Q, Wu G, Chu C, Li L, An L, Duan S.
Liu C, et al.
Clin Transl Oncol. 2024 Feb;26(2):557. doi: 10.1007/s12094-023-03346-8.
Clin Transl Oncol. 2024.
PMID: 37982971
No abstract available.
Item in Clipboard
Cite
Cite